Dabur challenges FSSAI order over ‘100 per cent’ claims on honey and ghee
Dabur India has moved court against an FSSAI order stopping sales of products carrying “100 per cent” claims. The FMCG major says it is revising affected labels, while operations at its Silvassa plant remain unaffected by a separate USFDA warning.
What happened
Dabur India has challenged FSSAI’s order halting sales of products carrying “100 per cent” claims, including honey and ghee. The FMCG company says affected
Key facts
- 100 per cent
- 2018
Why this matters
The case underscores the need for rigorous claims substantiation and regulatory diligence when assessing FMCG brands, portfolios or partnerships built around purity messaging.
What to watch
- Court decision on interim stay and whether existing inventory may continue to be sold.
- FSSAI clarification on the precise claims, SKUs and compliance deadline covered by the order.
- Evidence of stock withdrawals, retailer delistings, e-commerce availability declines or unusual discounting in Dabur honey and ghee.
- Timing of revised packs reaching modern trade, general trade and online channels.
- Competitor promotions, shelf-space expansion and market-share movement in branded honey and ghee.
- Any FSSAI follow-on notices involving other Dabur claims or sector-wide enforcement against '100 per cent', purity or natural-product wording.
- USFDA follow-up on the Silvassa plant and whether the issue affects exports, audits or domestic quality perceptions.
- Accelerate artwork approvals, packaging procurement and phased depletion or recall of non-compliant honey and ghee inventory.
- Seek interim judicial protection that permits sale of existing stock with corrective stickers, disclaimers or a defined transition period.
- Increase retailer and distributor communication to prevent delisting, unauthorized discounting and replacement of shelf space by competitors.
- Shift marketing from absolute '100 per cent' language toward traceability, sourcing, testing and product-quality claims that can be substantiated.
- Prepare for FSSAI requests on substantiation, batch testing, advertising archives and label governance across adjacent food and wellness products.
- Ring-fence the separate USFDA Silvassa issue in investor and trade communications, while reviewing whether it increases regulator and consumer scrutiny of quality-control systems.